Arrowhead Announces Proposed Underwritten Offering of Common Stock

[Business Wire] – Arrowhead Research Corporation , a biopharmaceutical company developing targeted RNAi therapeutics, today announced its intention to offer and sell shares of its common stock in an underwritten offering pursuant to its existing shelf re more

View todays social media effects on ARWR

View the latest stocks trending across Twitter. Click to view dashboard

See who Arrowhead is hiring next, click here to view